Federation Pharmacological Safety in Pregnancy: Modern Knowledge, Practice and Pharmacoepidemiological Approaches to the Studying and Recognizing of Drugs with Teratogenic Risk
One of the key issues in obstetric practice remains the lack or incompleteness of information on the teratogenicity of most drugs used by pregnant women. Uncertainty regarding teratogenic risks significantly affect the quality of information on drugs; nevertheless, counseling patients allows arrivin...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Paediatrician Publishers, LLC
2019-04-01
|
Series: | Pediatričeskaâ Farmakologiâ |
Subjects: | |
Online Access: | https://www.pedpharma.ru/jour/article/view/1692 |
id |
doaj-d67e4e62c78f40278db051307b1ffd1c |
---|---|
record_format |
Article |
spelling |
doaj-d67e4e62c78f40278db051307b1ffd1c2021-07-28T16:32:42ZengPaediatrician Publishers, LLCPediatričeskaâ Farmakologiâ1727-57762500-30892019-04-01161192910.15690/pf.v16i1.20001621Federation Pharmacological Safety in Pregnancy: Modern Knowledge, Practice and Pharmacoepidemiological Approaches to the Studying and Recognizing of Drugs with Teratogenic RiskKonstantin A. Lutsevich0Olga V. Reshetko1Saratov State Medical University named after V.I. RazumovskySaratov State Medical University named after V.I. RazumovskyOne of the key issues in obstetric practice remains the lack or incompleteness of information on the teratogenicity of most drugs used by pregnant women. Uncertainty regarding teratogenic risks significantly affect the quality of information on drugs; nevertheless, counseling patients allows arriving at a more balanced solution regarding their risk in pregnancy. Determination of the most commonly taken drugs (prescription or OTC) in the first trimester of gestation and increase of knowledge on their embryofetal risks optimizes pharmacotherapy during pregnancy. Characteristics and epidemiological analysis of possible factors, including drugs, associated with the occurrence of congenital anomalies, are crucial for the development of prevention activities that have an impact on the incidence of defects.https://www.pedpharma.ru/jour/article/view/1692pharmacoepidemiologypregnancydrugssafetydevelopmental toxicityteratogenic riskcongenital anomalies |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Konstantin A. Lutsevich Olga V. Reshetko |
spellingShingle |
Konstantin A. Lutsevich Olga V. Reshetko Federation Pharmacological Safety in Pregnancy: Modern Knowledge, Practice and Pharmacoepidemiological Approaches to the Studying and Recognizing of Drugs with Teratogenic Risk Pediatričeskaâ Farmakologiâ pharmacoepidemiology pregnancy drugs safety developmental toxicity teratogenic risk congenital anomalies |
author_facet |
Konstantin A. Lutsevich Olga V. Reshetko |
author_sort |
Konstantin A. Lutsevich |
title |
Federation Pharmacological Safety in Pregnancy: Modern Knowledge, Practice and Pharmacoepidemiological Approaches to the Studying and Recognizing of Drugs with Teratogenic Risk |
title_short |
Federation Pharmacological Safety in Pregnancy: Modern Knowledge, Practice and Pharmacoepidemiological Approaches to the Studying and Recognizing of Drugs with Teratogenic Risk |
title_full |
Federation Pharmacological Safety in Pregnancy: Modern Knowledge, Practice and Pharmacoepidemiological Approaches to the Studying and Recognizing of Drugs with Teratogenic Risk |
title_fullStr |
Federation Pharmacological Safety in Pregnancy: Modern Knowledge, Practice and Pharmacoepidemiological Approaches to the Studying and Recognizing of Drugs with Teratogenic Risk |
title_full_unstemmed |
Federation Pharmacological Safety in Pregnancy: Modern Knowledge, Practice and Pharmacoepidemiological Approaches to the Studying and Recognizing of Drugs with Teratogenic Risk |
title_sort |
federation pharmacological safety in pregnancy: modern knowledge, practice and pharmacoepidemiological approaches to the studying and recognizing of drugs with teratogenic risk |
publisher |
Paediatrician Publishers, LLC |
series |
Pediatričeskaâ Farmakologiâ |
issn |
1727-5776 2500-3089 |
publishDate |
2019-04-01 |
description |
One of the key issues in obstetric practice remains the lack or incompleteness of information on the teratogenicity of most drugs used by pregnant women. Uncertainty regarding teratogenic risks significantly affect the quality of information on drugs; nevertheless, counseling patients allows arriving at a more balanced solution regarding their risk in pregnancy. Determination of the most commonly taken drugs (prescription or OTC) in the first trimester of gestation and increase of knowledge on their embryofetal risks optimizes pharmacotherapy during pregnancy. Characteristics and epidemiological analysis of possible factors, including drugs, associated with the occurrence of congenital anomalies, are crucial for the development of prevention activities that have an impact on the incidence of defects. |
topic |
pharmacoepidemiology pregnancy drugs safety developmental toxicity teratogenic risk congenital anomalies |
url |
https://www.pedpharma.ru/jour/article/view/1692 |
work_keys_str_mv |
AT konstantinalutsevich federationpharmacologicalsafetyinpregnancymodernknowledgepracticeandpharmacoepidemiologicalapproachestothestudyingandrecognizingofdrugswithteratogenicrisk AT olgavreshetko federationpharmacologicalsafetyinpregnancymodernknowledgepracticeandpharmacoepidemiologicalapproachestothestudyingandrecognizingofdrugswithteratogenicrisk |
_version_ |
1721265527688527872 |